文献速递肿瘤 PET/CT核素与放射性配体治疗

成纤维细胞激活蛋白(FAP)显像的最新进展

The Latest Developments in Imaging of Fibroblast Activation Protein.
PubMed 文献 · J Nucl Med · 2020-10-30

FAP在超过90%上皮性肿瘤的癌症相关成纤维细胞中高表达,与肿瘤进展和不良预后相关。基于喹诺酮的FAP抑制剂(FAPI)经螯合剂偶联后对人及鼠FAP具有特异性结合和快速几乎完全的内化。由于高肿瘤摄取、正常组织极低蓄积及快速血液清除,FAPI PET/CT即使给药后10分钟也能获得高对比度图像,并在多种肿瘤实体的初始分期及复发转移(包括癌性腹膜炎)检测中优于18F-FDG PET/CT。

要点

  • FAP在超过90%上皮性肿瘤的癌症相关成纤维细胞中高表达,是诊疗有前景的靶点。
  • FAPI对FAP特异性结合并快速内化,正常组织蓄积低、血液清除快。
  • FAPI PET/CT给药后10分钟即可获得高对比度图像。

核心结论

  • FAP是放射性核素诊疗肿瘤及细胞外基质重塑相关非恶性疾病的有前景靶点。
  • FAPI PET/CT因高肿瘤摄取和低正常组织蓄积可获得高对比度图像。

研究设计与样本

  • 本文为综述,汇总FAP显像相关文献,未报告系统检索范围。

主要发现

  • FAP在超过90%上皮性肿瘤的癌症相关成纤维细胞中高表达,促进不同癌症进展和更差预后。
  • 多种喹诺酮类FAPI偶联螯合剂后对人及鼠FAP显示特异性结合,并快速几乎完全内化。
  • FAPI PET/CT因高肿瘤摄取、正常组织极低蓄积和快速血液清除,给药后10分钟即获高对比度。
  • FAPI PET/CT在多种肿瘤实体的初始分期及复发转移(包括癌性腹膜炎)检测中优于18F-FDG PET/CT。

临床怎么用

  • FAPI PET/CT可用于多种肿瘤实体的初始分期及复发转移检测,包括癌性腹膜炎。
  • FAPI PET/CT给药后10分钟即可成像,有利于快速获得高对比度图像。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fibroblast activation protein (FAP), a membrane-anchored peptidase, is highly expressed in cancer-associated fibroblasts in more than 90% of epithelial tumors and contributes to progression and worse prognosis of different cancers. Therefore, FAP is considered a promising target for radionuclide-based approaches for diagnosis and treatment of tumors and for the diagnosis of nonmalignant diseases associated with a remodeling of the extracellular matrix. Accordingly, a variety of quinolone-based FAP inhibitors (FAPIs) coupled to chelators were developed displaying specific binding to human and murine FAP with a rapid and almost complete internalization. Because of a high tumor uptake and a very low accumulation in normal tissues, as well as a rapid clearance from the circulation, a high contrast is obtained for FAPI PET/CT imaging even at 10 min after tracer administration. Moreover, FAPI PET/CT provides advantages over 18F-FDG PET/CT in several tumor entities for initial staging and detection of tumor recurrence and metastases, including peritonitis carcinomatosa.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Altmann A, Haberkorn U, Siveke J, et al. The Latest Developments in Imaging of Fibroblast Activation Protein. J Nucl Med. 2020. PMID: 33127618. doi:10.2967/jnumed.120.244806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。